About this trial
This intensive longitudinal study investigates the day-to-day stability and natural fluctuations of the gut microbiome in healthy adults over a 15-day period. While the human gut microbiome is a complex ecosystem, its baseline stability in the absence of disease or medical intervention remains insufficiently characterized due to low sampling frequency in prior research. By recruiting healthy volunteers for continuous daily sampling, this study aims to map temporal community structures and evaluate the stability of core microbiota. Additionally, the research utilizes Continuous Glucose Monitoring (CGM) to explore the potential relationships between microbiome dynamics, daily dietary intake, and host glycemic stability.
Eligibility criteria
Qualifiers
Participants reside in Hangzhou
Disqualifiers
Refusing or unable to give informed consent
Participants with chronic gastrointestinal diseases and take daily relevant medications
Participants with metabolic diseases including diabetes, hypertension and cardiovascular diseases (CVD)
Participants with craniocerebral trauma, cancer, liver disease, kidney disease, or other critical illness, or history of operation or medication
Trial design
Treatments tested in this trial
- Not listed